{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:47:02Z","timestamp":1787320022449,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,11]]},"DOI":"10.7759\/cureus.52079","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T05:21:52Z","timestamp":1704950512000},"source":"Crossref","is-referenced-by-count":3,"title":["Retrospective Evaluation of Bone Metastases in Patients With Thyroid Malignancy: A Single-Center Experience"],"prefix":"10.7759","author":[{"given":"M\u00fcge","family":"Ya\u015far","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ensar","family":"Aydemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Co\u015fkun","family":"Ate\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filiz","family":"Mercan Sar\u0131da\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erhan","family":"Hocao\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bu\u011fra Taygun","family":"G\u00fclle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zen","family":"\u00d6z G\u00fcl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soner","family":"Cander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdin\u00e7","family":"Ert\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canan","family":"Ersoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2020.100282","article-title":"Bone metastases in thyroid cancer","volume":"21","author":"I\u00f1iguez-Ariza NM","year":"2020","unstructured":"I\u00f1iguez-Ariza NM, Bible KC, Clarke BL. Bone metastases in thyroid cancer. J Bone Oncol. 2020, 21:100282. 10.1016\/j.jbo.2020.100282","journal-title":"J Bone Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-2838","article-title":"Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy","volume":"91","author":"Durante C","year":"2006","unstructured":"Durante C, Haddy N, Baudin E, et al.. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab. 2006, 91:2892-9. 10.1210\/jc.2005-2838","journal-title":"J Clin Endocrinol Metab"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01374-7","article-title":"Bone metastases from differentiated thyroid carcinoma: current knowledge and open issues","volume":"44","author":"Nervo A","year":"2021","unstructured":"Nervo A, Ragni A, Retta F, et al.. Bone metastases from differentiated thyroid carcinoma: current knowledge and open issues. J Endocrinol Invest. 2021, 44:403-19. 10.1007\/s40618-020-01374-7","journal-title":"J Endocrinol Invest"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-3906","article-title":"Skeletal complications and mortality in thyroid cancer: a population-based study","volume":"102","author":"Choksi P","year":"2017","unstructured":"Choksi P, Papaleontiou M, Guo C, Worden F, Banerjee M, Haymart M. Skeletal complications and mortality in thyroid cancer: a population-based study. J Clin Endocrinol Metab. 2017, 102:1254-60. 10.1210\/jc.2016-3906","journal-title":"J Clin Endocrinol Metab"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-1211","article-title":"Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels","volume":"92","author":"Giraudet AL","year":"2007","unstructured":"Giraudet AL, Vanel D, Leboulleux S, et al.. Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels. J Clin Endocrinol Metab. 2007, 92:4185-90. 10.1210\/jc.2007-1211","journal-title":"J Clin Endocrinol Metab"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-2815","article-title":"Bone metastases and skeletal-related events in medullary thyroid carcinoma","volume":"101","author":"Xu JY","year":"2016","unstructured":"Xu JY, Murphy WA Jr, Milton DR, et al.. Bone metastases and skeletal-related events in medullary thyroid carcinoma. J Clin Endocrinol Metab. 2016, 101:4871-7. 10.1210\/jc.2016-2815","journal-title":"J Clin Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-07-0229","article-title":"Bone metastases from differentiated thyroid carcinoma","volume":"15","author":"Muresan MM","year":"2008","unstructured":"Muresan MM, Olivier P, Lecl\u00e8re J, et al.. Bone metastases from differentiated thyroid carcinoma. Endocr Relat Cancer. 2008, 15:37-49. 10.1677\/ERC-07-0229","journal-title":"Endocr Relat Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2005.03.011","article-title":"Management of bone metastases in cancer: a review","volume":"56","author":"Selvaggi G","year":"2005","unstructured":"Selvaggi G, Scagliotti GV. Management of bone metastases in cancer: a review. Crit Rev Oncol Hematol. 2005, 56:365-78. 10.1016\/j.critrevonc.2005.03.011","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.4.7390","article-title":"Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas","volume":"86","author":"Bernier MO","year":"2001","unstructured":"Bernier MO, Leenhardt L, Hoang C, et al.. Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas. J Clin Endocrinol Metab. 2001, 86:1568-73. 10.1210\/jcem.86.4.7390","journal-title":"J Clin Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000002626","article-title":"Thyroid cancer bone metastasis: survival and genomic characteristics of a large tertiary care cohort","volume":"44","author":"Kondraciuk JD","year":"2019","unstructured":"Kondraciuk JD, Rice SL, Zhou X, et al.. Thyroid cancer bone metastasis: survival and genomic characteristics of a large tertiary care cohort. Clin Nucl Med. 2019, 44:e465-71. 10.1097\/RLU.0000000000002626","journal-title":"Clin Nucl Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1169","article-title":"Skeletal-related events due to bone metastases from differentiated thyroid cancer","volume":"97","author":"Farooki A","year":"2012","unstructured":"Farooki A, Leung V, Tala H, Tuttle RM. Skeletal-related events due to bone metastases from differentiated thyroid cancer. J Clin Endocrinol Metab. 2012, 97:2433-9. 10.1210\/jc.2012-1169","journal-title":"J Clin Endocrinol Metab"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4158\/EP-2018-0465","article-title":"Long-term outcomes and prognostic factors in patients with differentiated thyroid carcinoma and bone metastases","volume":"25","author":"Slook O","year":"2019","unstructured":"Slook O, Levy S, Slutzky-Shraga I, et al.. Long-term outcomes and prognostic factors in patients with differentiated thyroid carcinoma and bone metastases. Endocr Pract. 2019, 25:427-37. 10.4158\/EP-2018-0465","journal-title":"Endocr Pract"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1999.9.1227","article-title":"Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases","volume":"9","author":"Lin JD","year":"1999","unstructured":"Lin JD, Huang MJ, Juang JH, et al.. Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases. Thyroid. 1999, 9:1227-35. 10.1089\/thy.1999.9.1227","journal-title":"Thyroid"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4137\/cmo.s333","article-title":"Thyroid carcinoma with bone metastases: a prognostic factor study","volume":"2","author":"Wu K","year":"2008","unstructured":"Wu K, Hou SM, Huang TS, Yang RS. Thyroid carcinoma with bone metastases: a prognostic factor study. Clin Med Oncol. 2008, 2:129-34. 10.4137\/cmo.s333","journal-title":"Clin Med Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-017-1455-6","article-title":"Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience","volume":"59","author":"Mazziotti G","year":"2018","unstructured":"Mazziotti G, Formenti AM, Panarotto MB, et al.. Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience. Endocrine. 2018, 59:90-101. 10.1007\/s12020-017-1455-6","journal-title":"Endocrine"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-020-04952-2","article-title":"Clinical impact of follicular oncocytic (H\u00fcrthle cell) carcinoma in comparison with corresponding classical follicular thyroid carcinoma","volume":"48","author":"Wenter V","year":"2021","unstructured":"Wenter V, Albert NL, Unterrainer M, et al.. Clinical impact of follicular oncocytic (H\u00fcrthle cell) carcinoma in comparison with corresponding classical follicular thyroid carcinoma. Eur J Nucl Med Mol Imaging. 2021, 48:449-60. 10.1007\/s00259-020-04952-2","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/hed.26987","article-title":"The differences in distant metastatic patterns and their corresponding survival between thyroid cancer subtypes","volume":"44","author":"Vuong HG","year":"2022","unstructured":"Vuong HG, Le MK, Hassell L, Kondo T, Kakudo K. The differences in distant metastatic patterns and their corresponding survival between thyroid cancer subtypes. Head Neck. 2022, 44:926-32. 10.1002\/hed.26987","journal-title":"Head Neck"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/hed.24655","article-title":"Systematic review of site distribution of bone metastases in differentiated thyroid cancer","volume":"39","author":"Osorio M","year":"2017","unstructured":"Osorio M, Moubayed SP, Su H, Urken ML. Systematic review of site distribution of bone metastases in differentiated thyroid cancer. Head Neck. 2017, 39:812-8. 10.1002\/hed.24655","journal-title":"Head Neck"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2000.10.261","article-title":"Bone metastases from thyroid carcinoma: clinical characteristics and prognostic variables in one hundred forty-six patients","volume":"10","author":"Pittas AG","year":"2000","unstructured":"Pittas AG, Adler M, Fazzari M, Tickoo S, Rosai J, Larson SM, Robbins RJ. Bone metastases from thyroid carcinoma: clinical characteristics and prognostic variables in one hundred forty-six patients. Thyroid. 2000, 10:261-8. 10.1089\/thy.2000.10.261","journal-title":"Thyroid"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1159\/000494719","article-title":"Bone metastases from thyroid carcinoma of follicular origin: a single institutional experience","volume":"8","author":"Matta-Coelho C","year":"2019","unstructured":"Matta-Coelho C, Sim\u00f5es-Pereira J, Vilar H, Leite V. Bone metastases from thyroid carcinoma of follicular origin: a single institutional experience. Eur Thyroid J. 2019, 8:96-101. 10.1159\/000494719","journal-title":"Eur Thyroid J"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13174429","article-title":"Current management of bone metastases from differentiated thyroid cancer","volume":"13","author":"Kato S","year":"2021","unstructured":"Kato S, Demura S, Shinmura K, Yokogawa N, Shimizu T, Tsuchiya H. Current management of bone metastases from differentiated thyroid cancer. Cancers (Basel). 2021, 13:10.3390\/cancers13174429","journal-title":"Cancers (Basel)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-0093","article-title":"Efficacy and survival analysis of 131I therapy for bone metastases from differentiated thyroid cancer","volume":"96","author":"Qiu ZL","year":"2011","unstructured":"Qiu ZL, Song HJ, Xu YH, Luo QY. Efficacy and survival analysis of 131I therapy for bone metastases from differentiated thyroid cancer. J Clin Endocrinol Metab. 2011, 96:3078-86. 10.1210\/jc.2011-0093","journal-title":"J Clin Endocrinol Metab"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-17-0542","article-title":"Treatment of refractory thyroid cancer","volume":"25","author":"Berdelou A","year":"2018","unstructured":"Berdelou A, Lamartina L, Klain M, Leboulleux S, Schlumberger M. Treatment of refractory thyroid cancer. Endocr Relat Cancer. 2018, 25:R209-23. 10.1530\/ERC-17-0542","journal-title":"Endocr Relat Cancer"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-022-05697-w","article-title":"Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survival","volume":"49","author":"Jannin A","year":"2022","unstructured":"Jannin A, Lamartina L, Moutarde C, et al.. Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survival. Eur J Nucl Med Mol Imaging. 2022, 49:2401-13. 10.1007\/s00259-022-05697-w","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.2717","article-title":"Phase II trial of sorafenib in metastatic thyroid cancer","volume":"27","author":"Kloos RT","year":"2009","unstructured":"Kloos RT, Ringel MD, Knopp MV, et al.. Phase II trial of sorafenib in metastatic thyroid cancer. J Clin Oncol. 2009, 27:1675-84. 10.1200\/JCO.2008.18.2717","journal-title":"J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/214623-retrospective-evaluation-of-bone-metastases-in-patients-with-thyroid-malignancy-a-single-center-experience","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T15:11:25Z","timestamp":1707491485000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/214623-retrospective-evaluation-of-bone-metastases-in-patients-with-thyroid-malignancy-a-single-center-experience"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,11]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.52079","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,11]]}}}